--- title: "KCO: Sales rose but profitability declined in Q2 2026, with a strategic shift to value-added services" type: "News" locale: "en" url: "https://longbridge.com/en/news/294912642.md" description: "Q2 2026 saw higher sales but lower gross profit and net income, mainly due to divestments and a significant write-down at Becker. The company is shifting toward higher value-added business, with net debt rising and EBITDA guidance for FY 2026 set at €170–250m.Original document: Kloeckner & Co SE [KCO] Slides Release — Aug. 5 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source." datetime: "2026-08-05T05:05:45.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294912642.md) - [en](https://longbridge.com/en/news/294912642.md) - [zh-HK](https://longbridge.com/zh-HK/news/294912642.md) generator: "portal-rs" --- # KCO: Sales rose but profitability declined in Q2 2026, with a strategic shift to value-added services Q2 2026 saw higher sales but lower gross profit and net income, mainly due to divestments and a significant write-down at Becker. The company is shifting toward higher value-added business, with net debt rising and EBITDA guidance for FY 2026 set at €170–250m. Original document: Kloeckner & Co SE \[KCO\] Slides Release — Aug. 5 2026 **Disclaimer** This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source. ### Related Stocks - [KCO.DE](https://longbridge.com/en/quote/KCO.DE.md) ## Related News & Research - [Klöckner voting rights: Ben Durham lifts stake to 5% from 3.17%](https://longbridge.com/en/news/295806444.md) - [Russel Metals posts investor deck highlighting record revenue and shipments in Q2 2026](https://longbridge.com/en/news/295693263.md) - [INVEST: Revenue and profit dropped sharply in H1 2026, with 2026 outlook remaining subdued](https://longbridge.com/en/news/296439091.md) - [EGTX: Q2 2026 revenue up 23% YoY; U.S. Emcitate launch expected Q4 2026 pending FDA approval](https://longbridge.com/en/news/296636890.md) - [Plazza posts H1 2026 interim report online](https://longbridge.com/en/news/296736136.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**